2. Cell Cycle/DNA Damage
  3. CDK
  4. Olomoucine II

Olomoucine II is a potent CDK inhibitor with IC50 values of 0.06, 0.1, 0.45, 7.6, 19.8 µM for CDK9/cyclin T, CDK2/cyclin E, CDK7/cyclin H, CDK1/cyclin B, CDK4/cyclin D1, respectively. Olomoucine II shows antiproliferative activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Olomoucine II

Olomoucine II 構造式

CAS 番号 : 500735-47-7

容量 価格（税別） 在庫状況 数量
1 mg $97 お問い合わせ 2 - 3 weeks 4 - 5 weeks 5 - 6 weeks 1 - 2 weeks
5 mg   お問い合わせ  
10 mg   お問い合わせ  
Synthetic products have potential research and development risk.

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Olomoucine II 関連抗体

Top Publications Citing Use of Products

CDK アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85 CDK10 CDK15 CDK17 CDK18 CDK20 PITSLRE

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Olomoucine II is a potent CDK inhibitor with IC50 values of 0.06, 0.1, 0.45, 7.6, 19.8 µM for CDK9/cyclin T, CDK2/cyclin E, CDK7/cyclin H, CDK1/cyclin B, CDK4/cyclin D1, respectively. Olomoucine II shows antiproliferative activity[1].

IC50 & Target[1]

CDK9/cycT

0.06 μM (IC50)

CDK2/cyclinE

0.1 μM (IC50)

CDK7/cyclin H

0.45 μM (IC50)

Cdk1/cyclin B

7.6 μM (IC50)

CDK4/cyclinD1

19.8 μM (IC50)

Cellular Effect
Cell Line Type Value Description References
BJ EC50
5.4 μM
Compound: olomoucine II
Cytotoxicity against human BJ cells assessed as viable cells after 72 hrs by calcein AM assay
Cytotoxicity against human BJ cells assessed as viable cells after 72 hrs by calcein AM assay
[PMID: 20192247]
CCRF-CEM EC50
8.1 μM
Compound: olomoucine II
Cytotoxicity against human CEM cells assessed as viable cells after 72 hrs by calcein AM assay
Cytotoxicity against human CEM cells assessed as viable cells after 72 hrs by calcein AM assay
[PMID: 20192247]
CCRF-CEM IC50
3 μM
Compound: Olomoucine II
In vitro cytotoxic effect on CEM cancer cell line
In vitro cytotoxic effect on CEM cancer cell line
[PMID: 12392733]
CCRF-CEM IC50
7.4 μM
Compound: Olomoucine II
Cytotoxicity against human CEM cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
Cytotoxicity against human CEM cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
[PMID: 22770608]
G-361 IC50
6.3 μM
Compound: Olomoucine II
In vitro cytotoxic effect on G361 cancer cell line
In vitro cytotoxic effect on G361 cancer cell line
[PMID: 12392733]
G-361 IC50
9.2 μM
Compound: Olomoucine II
Cytotoxicity against human G361 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
Cytotoxicity against human G361 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
[PMID: 22770608]
HCT-116 IC50
4.1 μM
Compound: Olomoucine II
Cytotoxicity against human HCT116 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
Cytotoxicity against human HCT116 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
[PMID: 22770608]
HOS IC50
10.6 μM
Compound: Olomoucine II
Cytotoxicity against human HOS cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
Cytotoxicity against human HOS cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
[PMID: 22770608]
HOS IC50
6.3 μM
Compound: Olomoucine II
In vitro cytotoxic effect on HOS cancer cell line
In vitro cytotoxic effect on HOS cancer cell line
[PMID: 12392733]
HeLa EC50
9.9 μM
Compound: olomoucine II
Cytotoxicity against human HeLa cells assessed as viable cells after 72 hrs by calcein AM assay
Cytotoxicity against human HeLa cells assessed as viable cells after 72 hrs by calcein AM assay
[PMID: 20192247]
K562 IC50
11.1 μM
Compound: Olomoucine II
In vitro cytotoxic effect on K562 cancer cell line
In vitro cytotoxic effect on K562 cancer cell line
[PMID: 12392733]
K562 IC50
23 μM
Compound: Olomoucine II
Cytotoxicity against human K562 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
Cytotoxicity against human K562 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
[PMID: 22770608]
MCF7 EC50
4.6 μM
Compound: olomoucine II
Cytotoxicity against human MCF7 cells assessed as viable cells after 72 hrs by calcein AM assay
Cytotoxicity against human MCF7 cells assessed as viable cells after 72 hrs by calcein AM assay
[PMID: 20192247]
MCF7 IC50
5.3 μM
Compound: Olomoucine II
In vitro cytotoxic effect on MCF-7 cancer cell line
In vitro cytotoxic effect on MCF-7 cancer cell line
[PMID: 12392733]
MCF7 IC50
9.1 μM
Compound: Olomoucine II
Cytotoxicity against human MCF7 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
Cytotoxicity against human MCF7 cells assessed as reduction in number of viable cells after 72 hrs by fluorescence assay
[PMID: 22770608]
RPMI-8226 EC50
6 μM
Compound: olomoucine II
Cytotoxicity against human RPMI8226 cells assessed as viable cells after 72 hrs by calcein AM assay
Cytotoxicity against human RPMI8226 cells assessed as viable cells after 72 hrs by calcein AM assay
[PMID: 20192247]
Sf9 IC50
50 nM
Compound: Olomoucine II
Inhibition of CDK2/Cyclin E (unknown origin) expressed in Sf9 cells using histone H1 as substrate
Inhibition of CDK2/Cyclin E (unknown origin) expressed in Sf9 cells using histone H1 as substrate
[PMID: 22770608]
U-266 EC50
7.2 μM
Compound: olomoucine II
Cytotoxicity against human U266 cells assessed as viable cells after 72 hrs by calcein AM assay
Cytotoxicity against human U266 cells assessed as viable cells after 72 hrs by calcein AM assay
[PMID: 20192247]
体外実験

Olomoucine II (72 h) shows antiproliferative activity with IC50s of 9.3, 9.2, 10.5, 13.6, 5.0, 10.8, 5.3, 2.7, 16.3 µM for HOS, T98G, HBL100, BT474, MCF-7, HT-29, CCRF-CEM, BV173, HL60 cells, respectively[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Olomoucine II 関連抗体

Cell Proliferation Assay[1]

Cell Line: HOS, T98G, HBL100, BT474, MCF-7, HT-29, CCRF-CEM, BV173, HL60 cells
Concentration:
Incubation Time: 72 h
Result: Showed antiproliferative activity with IC50s of 9.3, 9.2, 10.5, 13.6, 5.0, 10.8, 5.3, 2.7, 16.3 µM for HOS, T98G, HBL100, BT474, MCF-7, HT-29, CCRF-CEM, BV173, HL60 cells, respectively.
分子量

370.45

分子式

C19H26N6O2
CAS 番号
SMILES

OC1=CC=CC=C1CNC2=C3N=CN(C(C)C)C3=NC(N[C@@H](CO)CC)=N2
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Olomoucine II Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Olomoucine II500735-47-7CDKCyclin dependent kinaseantiproliferativeArn8 cellsp53p21Inhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Olomoucine II
製品番号:
HY-112450
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.